LTFS
ADMS

Ladenburg Thalmann Financial Services’s Adamas Pharmaceuticals ADMS Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$0 Hold
50
– – ﹤0.01% 5603
2019
Q3 		$0 Hold
50
– – ﹤0.01% 5554
2019
Q2 		$0 Hold
50
– – ﹤0.01% 5494
2019
Q1 		$0 Hold
50
– – ﹤0.01% 5413
2018
Q4 		$0 Hold
50
– – ﹤0.01% 5413
2018
Q3 		$1K Sell
50
-215
-81% -$5.05K ﹤0.01% 5079
2018
Q2 		$6K Hold
265
– – ﹤0.01% 4543
2018
Q1 		$6K Sell
265
-950
-78% -$30K ﹤0.01% 4543
2017
Q4 		$42K Sell
1,215
-26
-2% -$726 ﹤0.01% 3349
2017
Q3 		$26K Buy
+1,241
New +$22.8K ﹤0.01% 3535
2017
Q2 		– Sell
-100
Closed -$2K – 5016
2017
Q1 		$2K Buy
+100
New +$1.7K ﹤0.01% 4617
2015
Q3 		– Sell
-4
Closed – – 4787
2015
Q2 		$0 Hold
4
– – ﹤0.01% 4796
2015
Q1 		$0 Buy
+4
New +$69 ﹤0.01% 4690

Other funds holding ADMS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ADMS Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Adamas Pharmaceuticals (ADMS) position steady in Q4 2019 at 50 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5603.

Ladenburg Thalmann Financial Services first reported a position in ADMS in Q1 2015 and has held it in 13 quarters since. The position peaked at $42K in Q4 2017. 79 funds tracked by Wall St. Rank hold ADMS as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 50 shares of Adamas Pharmaceuticals worth $0 as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its Adamas Pharmaceuticals share count unchanged in Q4 2019.
  • Adamas Pharmaceuticals made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5603 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Adamas Pharmaceuticals in Q1 2015 and has held it in 13 quarters since.
  • Ladenburg Thalmann Financial Services's Adamas Pharmaceuticals position peaked at $42K in Q4 2017.
  • 79 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.